Expert opinion on the treatment of patients with chronic hepatitis C
โ Scribed by S. Zeuzem; T. Berg; B. Moeller; H. Hinrichsen; S. Mauss; H. Wedemeyer; C. Sarrazin; D. Hueppe; E. Zehnter; M. P. Manns
- Book ID
- 108886167
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 743 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1352-0504
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Treatment of patients with chronic hepatitis C has had limited success because of relapses and nonresponse to interferon alfa therapy (currently the only established therapeutic agent). A retrospective study was done to determine the efficacy of re-treatment with interferon and the predictors of res
Our algorithm cannot be directly applied to other populations directly because clinical backgrounds differ among countries. However, we think that our study is applicable on a global scale because it has clearly shown that a combination of viral and host factors is effective for predicting the respo
Hepatitis C virus (HCV) infection is especially problematic in patients with end-stage renal disease (ESRD) who are undergoing hemodialysis. Rates of HCV infection are higher among hemodialysis patients than in the general population, and several routes of transmission are thought to stem from the d
We report 13 patients (10 with chronic hepatitis C, 1 with chronic hepatitis B, 2 with nonalcoholic steatohepatitis) with persistently elevated alanine aminotransferase (ALT) levels who were treated with dimethyl-4,4-dimethoxy-5,6,5,6-dimethylenedioxybiphenyl-2,2 dicarboxylate (DDB). ALT rapidly nor